AdaptHealth Corp.
AHCO
$9.02
-$0.02-0.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.25B | 3.26B | 3.26B | 3.26B | 3.25B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.25B | 3.26B | 3.26B | 3.26B | 3.25B |
| Cost of Revenue | 2.49B | 2.47B | 2.49B | 2.50B | 2.50B |
| Gross Profit | 754.43M | 789.76M | 773.75M | 759.80M | 751.49M |
| SG&A Expenses | 436.91M | 439.20M | 425.98M | 422.53M | 410.20M |
| Depreciation & Amortization | 44.09M | 45.05M | 45.51M | 48.77M | 52.92M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.97B | 2.96B | 2.96B | 2.97B | 2.96B |
| Operating Income | 273.42M | 305.51M | 302.26M | 288.50M | 288.37M |
| Income Before Tax | 125.29M | 136.02M | -206.38M | -725.91M | -733.24M |
| Income Tax Expenses | 35.48M | 41.24M | 3.82M | -38.83M | -40.68M |
| Earnings from Continuing Operations | 89.81 | 94.78 | -210.20 | -687.07 | -692.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.46M | -4.36M | -4.15M | -4.20M | -4.17M |
| Net Income | 85.35M | 90.42M | -214.34M | -691.28M | -696.74M |
| EBIT | 273.42M | 305.51M | 302.26M | 288.50M | 288.37M |
| EBITDA | 640.22M | 670.84M | 669.42M | 662.22M | 670.22M |
| EPS Basic | 0.58 | 0.62 | -1.64 | -5.16 | -5.18 |
| Normalized Basic EPS | 0.72 | 0.82 | 0.82 | 0.78 | 0.76 |
| EPS Diluted | 0.56 | 0.60 | -1.67 | -5.26 | -5.28 |
| Normalized Diluted EPS | 0.71 | 0.81 | 0.81 | 0.78 | 0.76 |
| Average Basic Shares Outstanding | 536.90M | 535.01M | 533.43M | 533.95M | 535.02M |
| Average Diluted Shares Outstanding | 543.89M | 542.01M | 538.46M | 536.92M | 537.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |